Medicox메디콕스
054180 · KOSDAQ · ₩054180 · 메디콕스
₩2,295 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩28B | ₩31B | ₩27B | ₩22B | ₩17B |
| Cost of sales | ₩26B | ₩29B | ₩25B | ₩21B | ₩17B |
| Gross profit | ₩2.2B | ₩2B | ₩1.9B | ₩659M | ₩505M |
| Operating income | −₩5.7B | −₩10B | −₩11B | −₩12B | −₩9.3B |
| Net income | −₩12B | −₩21B | −₩34B | −₩43B | −₩24B |
| Net income to shareholders | −₩12B | −₩21B | −₩34B | −₩43B | −₩24B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩68B | ₩81B | ₩98B | ₩110B | ₩102B |
| Current assets | ₩7.5B | ₩13B | ₩30B | ₩43B | ₩26B |
| Cash and equivalents | ₩377M | ₩1.2B | ₩1.8B | ₩3B | ₩4.2B |
| Total liabilities | ₩21B | ₩29B | ₩34B | ₩47B | ₩36B |
| Current liabilities | ₩16B | ₩24B | ₩31B | ₩44B | ₩33B |
| Borrowings | ₩8.5B | ₩18B | ₩15B | ₩16B | ₩18B |
| Total equity | ₩47B | ₩52B | ₩63B | ₩63B | ₩66B |
| Shareholders' equity | ₩47B | ₩52B | ₩63B | ₩63B | ₩66B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩3.4B | −₩6.6B | −₩8.9B | −₩9.2B | −₩7.2B |
| Capital spending | ₩774M | ₩366M | ₩448M | ₩3.7B | ₩1.6B |
| Free cash flow | −₩4.2B | −₩7B | −₩9.3B | −₩13B | −₩8.8B |
Consolidated where available. Amounts in won.
Also known as: Medicox / 메디콕스 / 054180 / KRX:054180
Source: KRX statistical information